Pictet Asset Management
PRCT icon

Pictet Asset Management’s Procept Biorobotics PRCT Stock Holding History

Pictet Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Hold
9,230
– – ﹤0.01% 1974
2026
Q1 		$231K Buy
9,230
+1,626
+21% +$45.8K ﹤0.01% 1877
2025
Q4 		$239K Hold
7,604
– – ﹤0.01% 1827
2025
Q3 		$271K Sell
7,604
-1,723
-18% -$78.7K ﹤0.01% 1706
2025
Q2 		$536K Buy
9,327
+580
+7% +$32.8K ﹤0.01% 1330
2025
Q1 		$513K Sell
8,747
-579
-6% -$39.5K ﹤0.01% 1347
2024
Q4 		$751K Buy
9,326
+1,991
+27% +$170K ﹤0.01% 1220
2024
Q3 		$587K Buy
7,335
+2,168
+42% +$154K ﹤0.01% 1273
2024
Q2 		$316K Hold
5,167
– – ﹤0.01% 1504
2024
Q1 		$255K Hold
5,167
– – ﹤0.01% 1628
2023
Q4 		$217K Buy
+5,167
New +$176K ﹤0.01% 1706

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pictet Asset Management's PRCT Position: Q2 2026 in Review

Pictet Asset Management held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 9,230 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

Pictet Asset Management first reported a position in PRCT in Q4 2023 and has held it in 11 quarters since. The position peaked at $751K in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Pictet Asset Management held 9,230 shares of Procept Biorobotics worth $208K as of Q2 2026.
  • Pictet Asset Management left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1974 holding.
  • Pictet Asset Management first reported a position in Procept Biorobotics in Q4 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's Procept Biorobotics position peaked at $751K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.